WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.

Yadav VR, Prasad S, Reuter S, Sung B, Yamamoto N, Murakami A, Aggarwal BB

Open source

DOI
10.1016/j.canlet.2011.12.011
Published
2011 Dec 17
Container
Cancer letters
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.canlet.2011.12.011,
  title = {WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.},
  author = {Yadav VR and Prasad S and Reuter S and Sung B and Yamamoto N and Murakami A and Aggarwal BB},
  year = {2011},
  journal = {Cancer letters},
  doi = {10.1016/j.canlet.2011.12.011},
  url = {https://doi.org/10.1016/j.canlet.2011.12.011}
}

RIS

TY  - JOUR
TI  - WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.
AU  - Yadav VR
AU  - Prasad S
AU  - Reuter S
AU  - Sung B
AU  - Yamamoto N
AU  - Murakami A
AU  - Aggarwal BB
PY  - 2011
JO  - Cancer letters
DO  - 10.1016/j.canlet.2011.12.011
UR  - https://doi.org/10.1016/j.canlet.2011.12.011
ER  - 

APA

VR, Y., S, P., S, R., B, S., N, Y., A, M., & BB, A. (2011). WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.. Cancer letters. https://doi.org/10.1016/j.canlet.2011.12.011

Source records